Woodline Partners LP - SILVERBACK THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Woodline Partners LP ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,201,864
-28.7%
847,054
+26.4%
0.04%
-28.3%
Q2 2023$4,489,583
+14.9%
670,087
+11.7%
0.05%0.0%
Q1 2023$3,906,000
-63.7%
600,000
-52.4%
0.05%
-63.2%
Q4 2022$10,758,949
+150.7%
1,261,307
+55.2%
0.14%
+140.0%
Q3 2022$4,292,000
+1364.8%
812,899
+872.7%
0.06%
+1100.0%
Q1 2022$293,000
-91.1%
83,571
-83.1%
0.01%
-89.4%
Q4 2021$3,289,000
-22.5%
493,895
+16.1%
0.05%
-31.9%
Q3 2021$4,244,000
-63.6%
425,261
+12.6%
0.07%
-68.3%
Q2 2021$11,665,000
+29.4%
377,631
+82.7%
0.22%
+9.0%
Q1 2021$9,018,000
-9.7%
206,683
-4.1%
0.20%
-24.5%
Q4 2020$9,988,000215,5360.26%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Orbimed Advisors 8,740,887$87,234,0000.96%
Boxer Capital, LLC 1,675,377$16,720,0000.58%
EcoR1 Capital, LLC 1,184,710$11,823,0000.41%
Nantahala Capital Management 1,226,631$12,242,0000.39%
5AM Venture Management, LLC 169,748$1,694,0000.34%
COMMODORE CAPITAL LP 97,143$969,0000.26%
RA Capital Management 1,742,186$17,387,0000.24%
HighVista Strategies LLC 22,434$224,0000.15%
Rhenman & Partners Asset Management AB 150,000$1,497,0000.10%
Woodline Partners LP 425,261$4,244,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders